Vaginal Pessary Market By Product Type (Ring Pessaries, Gellhorn Pessaries, Cube Pessaries, Donut Pessaries, Inflatable Pessaries), By Application (Pelvic Organ Prolapse, Stress Urinary Incontinence, Prolapsed Uterus, Postpartum Conditions, Others), By End-User Industry (Healthcare Providers, Pharmaceutical Companies, Hospitals & Clinics, Retail Pharmacies, Online Pharmacies), By Distribution Channel (Direct Sales, Retail Pharmacies, Online Pharmacies, Hospitals & Clinics), and By Treatment Type (Prescription Pessaries, Over-the-Counter Pessaries); Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Vaginal Pessary Market was valued at USD 0.8 billion in 2024-e and will surpass USD 1.5 billion by 2030; growing at a CAGR of 8.9% during 2025 - 2030.

The vaginal pessary market has witnessed significant growth, driven by increasing awareness and rising demand for pelvic floor disorder treatments. Vaginal pessaries are widely used for conditions like pelvic organ prolapse, stress urinary incontinence, and post-childbirth support. The market is expected to grow as more women seek non-invasive treatments for these conditions, often as an alternative to surgery. Factors such as aging populations, growing healthcare access, and improved medical device options are pushing the demand for vaginal pessaries across different regions. Furthermore, innovations in material and design are enhancing comfort and effectiveness, further fueling market expansion.

Ring Pessaries Segment Is Largest Owing to Their Versatility

The Ring Pessary segment holds the largest share of the vaginal pessary market, owing to its versatility and high usage among patients. Ring pessaries are often the first choice for treating pelvic organ prolapse (POP) due to their simple design and efficacy in providing pelvic support. These devices are comfortable, easily inserted, and adjustable, making them a preferred option for both short-term and long-term use. Their popularity among healthcare providers and patients alike has led to a significant market share.

The widespread adoption of ring pessaries is also attributed to their availability in various sizes, ensuring that they can be tailored to fit patients' needs. Additionally, ring pessaries are easy to maintain and have minimal side effects, which further boosts their demand across healthcare facilities. These factors make the ring pessary segment the most prominent in the overall market.

Pelvic Organ Prolapse Application Is Fastest Growing Owing to Increased Awareness

Pelvic organ prolapse (POP) is the fastest growing application in the vaginal pessary market, driven by rising awareness about the condition and the benefits of using pessaries as a treatment option. POP is a condition in which the pelvic organs, such as the bladder or uterus, descend into the vaginal canal due to weakened pelvic muscles. It is common among women, especially those who have experienced childbirth, and those over 50.

The growing focus on women’s health and the demand for non-invasive treatment options have spurred the adoption of vaginal pessaries for managing POP. As more women seek alternatives to surgery, the pelvic organ prolapse application segment is expected to continue its rapid growth. This is further supported by advancements in pessary design, making them more comfortable and easier to use, which enhances their appeal as a long-term management solution for POP.

Healthcare Providers End-User Industry Is Largest Owing to Increased Adoption

The Healthcare Providers segment dominates the vaginal pessary market, as healthcare institutions such as hospitals, clinics, and gynecology centers are the primary points of care for women suffering from pelvic disorders. These establishments are responsible for the diagnosis, fitting, and management of pessaries, making them the largest end-user of the product. As the awareness surrounding pelvic health and non-surgical treatments increases, healthcare providers are increasingly adopting pessaries as a first-line treatment option.

Moreover, healthcare providers offer a more personalized fitting experience for patients, ensuring that the pessary is both effective and comfortable. This has contributed to the large market share of healthcare providers in the vaginal pessary market. The segment's prominence is also supported by healthcare providers’ ability to offer a range of pessary types tailored to different medical needs.

Direct Sales Distribution Channel Is Largest Owing to Efficient Access

The Direct Sales distribution channel is the largest in the vaginal pessary market due to the efficient access it provides to healthcare providers and patients alike. Direct sales allow manufacturers to sell pessaries directly to hospitals, clinics, and medical practices, ensuring quick delivery and ensuring the products meet specific medical standards. This distribution method is particularly effective in regions where healthcare providers prefer to deal directly with manufacturers for higher-quality products and greater assurance of service.

Additionally, direct sales facilitate customer support, training, and product education, which are critical in the proper use and fitting of vaginal pessaries. This not only ensures the efficacy of the product but also minimizes the risk of complications, making it an attractive option for both suppliers and end-users.

Prescription Pessaries Treatment Type Is Largest Owing to Medical Supervision

Prescription Pessaries dominate the vaginal pessary market, as these products are often recommended and prescribed by healthcare providers, ensuring they are used for the right conditions and fitted properly. Prescription pessaries are medically supervised, offering a higher level of care and better outcomes compared to over-the-counter options. These pessaries are customized to suit the individual’s medical needs, ensuring more effective management of conditions like pelvic organ prolapse and urinary incontinence.

The medical supervision provided with prescription pessaries also assures patients of proper follow-up care and fitting adjustments if necessary. This has made prescription pessaries the preferred choice for patients requiring a reliable, long-term treatment for pelvic health issues.

Fastest Growing Region Is North America Owing to Strong Healthcare Infrastructure

North America is the fastest growing region in the vaginal pessary market, driven by a strong healthcare infrastructure and growing awareness of women’s health issues. The United States, in particular, has seen an increase in demand for non-invasive treatments for pelvic health conditions. As more women become aware of alternatives to surgery, the use of vaginal pessaries for pelvic organ prolapse and urinary incontinence is expected to rise.

Furthermore, the region’s advanced medical technologies, along with increasing health insurance coverage, make it easier for patients to access treatment options like pessaries. The regulatory environment in North America also supports the growth of the vaginal pessary market, ensuring the availability of high-quality products that meet safety standards.

Competitive Landscape and Leading Companies

The vaginal pessary market is competitive, with numerous companies offering various pessary products designed for the treatment of pelvic organ prolapse, urinary incontinence, and related conditions. Leading companies in the market include Medtronic, CooperSurgical, Smith & Nephew, Boston Scientific, and Coloplast, all of which have made significant investments in developing innovative products and expanding their market presence.

The competition is expected to intensify with new entrants offering improved designs and greater comfort, further expanding the range of options available to patients. Companies are focusing on strengthening their product offerings through partnerships, acquisitions, and product innovations. The market's future growth will be influenced by increased awareness of pelvic health, as well as advancements in vaginal pessary technology that aim to enhance patient comfort and treatment outcomes.

Recent Developments:

• Medtronic announced the launch of a new line of vaginal pessaries designed for advanced pelvic organ prolapse treatment.
• CooperSurgical acquired a key competitor in the women's health space, strengthening its product portfolio in pelvic floor care.
• Boston Scientific received FDA approval for an innovative vaginal pessary system designed for improved patient comfort and efficacy.
• Smith & Nephew has expanded its vaginal pessary product range to include options for severe prolapse cases, enhancing treatment options.
• Coloplast has launched a digital platform for better management and monitoring of patients using vaginal pessaries.

List of Leading Companies:

• Medtronic
• CooperSurgical
• Boston Scientific
• Smith & Nephew
• Coloplast
• Johnson & Johnson
• Therapeutic Innovations
• Integra LifeSciences
• Baxter International
• Hologic
• Allergan
• Cook Medical
• Becton Dickinson and Company
• Kegel8
• Axonics Modulation Technologies

Report Scope: